The extracellular domain of neurotrophin receptor p75 as a candidate biomarker for amyotrophic lateral sclerosis

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Shepheard, Stephanie R ^a   Chataway, Tim ^a   Schultz, David W ^b   Rush, Robert A ^a   Rogers, Mary Louise ^a  

^a FLINDERS UNIVERSITY   (Australia)

^b FLINDERS MEDICAL CENTRE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; NEUROTROPHIN RECEPTOR P75;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOPRECIPITATION; MALE; MASS SPECTROMETRY; MOUSE; MSOD1 MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PARKINSON DISEASE; PILOT STUDY; URINALYSIS; WESTERN BLOTTING;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; BIOLOGICAL MARKERS; BLOTTING, WESTERN; CREATININE; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNOPRECIPITATION; MICE; MICE, INBRED C57BL; RECEPTOR, NERVE GROWTH FACTOR; SUPEROXIDE DISMUTASE;

EID: 84900334730     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0087398     Document Type: Article

References (48)

1. Ferraiuolo L, Kirby J, Grierson AJ, Sendtner M, Shaw PJ (2011) Molecular pathways of motor neuron injury in amyotrophic lateral sclerosis. Nature Reviews Neurology 7: 616-630.
2. Otto M, Bowser R, Turner M, Berry J, Brettschneider J, et al. (2012) Roadmap and standard operating procedures for biobanking and discovery of neurochemical markers in ALS. Amyotroph Lateral Scler 13: 1-10.
3. Kaufmann P, Levy G, Thompson JLP, Delbene ML, Battista V, et al. (2005) The ALSFRSr predicts survival time in an ALS clinic population. Neurology 64: 38-43. (Pubitemid 40082934)
4. Turner MR, Bowser R, Bruijn L, Dupuis L, Ludolph A, et al. (2013) Mechanisms, models and biomarkers in amyotrophic lateral sclerosis. Amyotroph Lateral Scler & Frontotemp Degen 14 Suppl 1: 19-32.
5. Kruger T, Lautenschlager J, Grosskreutz J, Rhode H (2013) Proteome analysis of body fluids for amyotrophic lateral sclerosis biomarker discovery. Proteomics Clin Appl 7: 123-135.
6. Cellura E, Spataro R, Taiello AC, La Bella V (2012) Factors affecting the diagnostic delay in amyotrophic lateral sclerosis. Clinical Neurol and Neurosurg 114: 550-554.
7. Bowser R, Turner MR, Shefner J (2011) Biomarkers in amyotrophic lateral sclerosis: opportunities and limitations. Nature Reviews Neurology 7: 631-638.
8. Ganesalingam J, An J, Shaw CE, Shaw G, Lacomis D, et al. (2011) Combination of neurofilament heavy chain and complement C3 as CSF biomarkers for ALS. Journal of Neurochem 117: 528-537.
9. Tortelli R, Ruggieri M, Cortese R, D'Errico E, Capozzo R, et al. (2012) Elevated cerebrospinal fluid neurofilament light levels in patients with amyotrophic lateral sclerosis: a possible marker of disease severity and progression. Eur J Neurol 19: 1561-1567.
10. Pasinetti GM, Ungar LH, Lange DJ, Yemul S, Deng H, et al. (2006) Identification of potential CSF biomarkers in ALS. Neurology 66: 1218-1222. (Pubitemid 43739707)
11. Yan Q, Johnson EM, Jr. (1988) An immunohistochemical study of the nerve growth factor receptor in developing rats. J Neurosci 8: 3481-3498.
12. Ferri CC, Moore FA, Bisby MA (1998) Effects of facial nerve injury on mouse motoneurons lacking the p75 low-affinity neurotrophin receptor. J Neurobiol 34: 1-9. (Pubitemid 28032422)
13. Kenchappa RS, Tep C, Korade Z, Urra S, Bronfman FC, et al. (2010) p75 neurotrophin receptor-mediated apoptosis in sympathetic neurons involves a biphasic activation of JNK and up-regulation of tumor necrosis factor-alpha-converting enzyme/ADAM17. J Biol Chem 285: 20358-20368.
14. DiStefano PS, Clagett-Dame M, Chelsea DM, Loy R (1991) Developmental regulation of human truncated nerve growth factor receptor. Ann Neurol 29: 13-20.
15. DiStefano PS, Johnson EM (1988) Identification of a truncated form of the nerve growth factor receptor. Proc Natl Acad Sci USA 85: 270-274. (Pubitemid 18055328)
16. Seeburger JL, Tarras S, Natter H, Springer JE (1993) Spinal cord motoneurons express p75NGFR and p145trkB mRNA in amyotrophic lateral sclerosis. Brain Res 621: 111-115. (Pubitemid 23242167)
17. Lowry K, Murray S, McLean C, Talman P, Mathers S, et al. (2001) A potential role for the p75 low-affinity neurotrophin receptor in spinal motor neuron degeneration in murine and human amyotrophic lateral sclerosis. Amyotroph Lateral Scler 2: 127-134. (Pubitemid 34013605)
18. Lynoe N, Sandlund M, Dahlqvist G, Jacobsson L (1991) Informed consent: study of quality of information given to participants in a clinical trial. British Medical Journ 303: 610-613.
19. Brooks BR, Miller RG, Swash M, Munsat TL, World Fed of Neurol Res Group on Motor Neuron Diseases (2000) El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler 1: 293-299.
20. Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55: 181-184.
21. Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, et al. (2011) Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Annals of Neurol 69: 292-302.
22. Yamamoto T (2010) The 4th Human Kidney and Urine Proteome Project (HKUPP) workshop. 26 September 2009, Toronto, Canada. Proteomics 10: 2069-2070.
23. Leitner ML, Menzies S, Lutz C (2009) Working with ALS mice; guidelines for preclinical testing & colony management. JaxMice: 1-28.
24. Miana-Mena FJ, Munoz MJ, Yague G, Mendez M, Moreno M, et al. (2005) Optimal methods to characterize the G93A mouse model of ALS. Amyotroph Lateral Scler 6: 55-62. (Pubitemid 40668249)
25. Rogers M, Atmosukarto I, Berhanu D, Matusica D, Macardle P, et al. (2006) Functional monoclonal antibodies to p75 neurotrophin receptor raised in knockout mice. J Neurosci Methods 158: 109-120. (Pubitemid 44550135)
26. Huh CY, Danik M, Manseau F, Trudeau LE, Williams S (2008) Chronic exposure to nerve growth factor increases acetylcholine and glutamate release from cholinergic neurons of the rat medial septum and diagonal band of Broca via mechanisms mediated by p75NTR. J Neurosci 28: 1404-1409. (Pubitemid 351231513)
27. Wilson CH, Zeile S, Chataway T, Nieuwenhuijs VB, Padbury RT, et al. (2011) Increased expression of peroxiredoxin 1 and identification of a novel lipid-metabolizing enzyme in the early phase of liver ischemia reperfusion injury. Proteomics 11: 4385-4396.
28. Zupan AA, Osborne PA, Smith CE, Siegel NR, Leimgruber RM, et al. (1989) Identification, purification, and characterization of truncated forms of the human nerve growth factor receptor. J Biol Chem 264: 11714-11720. (Pubitemid 19185338)
29. Baker SG, Krame BS (2007) Peirce, Youden, and Receiver Operating Characteristic Curves. The American Statistician 61: 343-346.
30. Rogers ML, Bailey S, Matusica D, Nicholson I, Muyderman H, et al. (2010) ProNGF mediates death of Natural Killer cells through activation of the p75NTR-sortilin complex. J Neuroimmunol 226: 93-103.
31. Ibanez CF, Simi A (2012) p75 neurotrophin receptor signaling in nervous system injury and degeneration: paradox and opportunity. Trends Neurosci 35: 431-440.
32. Kimura F, Fujimura C, Ishida S, Nakajima H, Furutama D, et al. (2006) Progression rate of ALSFRS-R at time of diagnosis predicts survival time in ALS. Neurology 66: 265-267. (Pubitemid 43970171)
33. Ono S, Imai T, Matsubara S, Takahashi K, Jinnai K, et al. (1999) Decreased urinary concentrations of type IV collagen in amyotrophic lateral sclerosis. Acta Neurol Scand 100: 111-116. (Pubitemid 29325318)
34. Thongboonkerd V, Chutipongtanate S, Kanlaya R (2006) Systematic evaluation of sample preparation methods for gel-based human urinary proteomics: quantity, quality, and variability. J Proteome Res 5: 183-191. (Pubitemid 43100811)
35. Mannen T (1991) [Neuropathology of Onuf's nucleus]. Rinsho Shinkeigaku 31: 1281-1285.
36. Copray J, Jaarsma D, Kust B, Bruggeman R, Mantingh I, et al. (2003) Expression of the low affinity neurotrophin receptor p75 in spinal motoneurons in a transgenic mouse model for amyotrophic lateral sclerosis. Neuroscience 116: 685-694. (Pubitemid 36160565)
37. DiStefano PS, Chelsea DM, Schick CM, McKelvy JF (1993) Involvement of a metalloprotease in low-affinity nerve growth factor receptor truncation: inhibition of truncation in vitro and in vivo. J Neurosci 13: 2405-2414. (Pubitemid 23151757)
38. Kerkhoff H, Jennekens FGI, Troost D, Veldman H (1991) Nerve growth factor receptor immunostaining in the spinal cord and peripheral nerves in amyotrophic lateral sclerosis. Acta Neuropathologica 81: 649-656.
39. Dowling P, Ming X, Raval S, Husar W, Casaccia-Bonnefil P, et al. (1999) Upregulated p75NTR neurotrophin receptor on glial cells in MS plaques. Neurology 53: 1676-1682. (Pubitemid 29530339)
40. Mufson EJ, Presley LN, Kordower JH (1991) Nerve growth factor receptor immunoreactivity within the nucleus basalis (Ch4) in Parkinson's disease: reduced cell numbers and co-localization with cholinergic neurons. Brain Res 539: 19-30.
41. Lindner MD, Gordon DD, Miller JM, Tariot PN, McDaniel KD, et al. (1993) Increased levels of truncated nerve growth factor receptor in urine of mildly demented patients with Alzheimer's disease. Arch of Neurology 50: 1054-1060.
42. Reitz C, Brayne C, Mayeux R (2011) Epidemiology of Alzheimer disease. Nature Reviews Neurology 7: 137-152.
43. Silani V, Messina S, Poletti B, Morelli C, Doretti A, et al. (2011) The diagnosis of Amyotrophic Lateral Sclerosis in 2010. Arch Ital Biol 149: 5-27.
44. Boylan K, Yang C, Crook J, Overstreet K, Heckman M, et al. (2009) Immunoreactivity of the phosphorylated axonal neurofilament H subunit (pNF-H) in blood of ALS model rodents and ALS patients: evaluation of blood pNF-H as a potential ALS biomarker. Journal of Neurochemistry 111: 1182-1191.
45. Boylan KB, Glass JD, Crook JE, Yang C, Thomas CS, et al. (2013) Phosphorylated neurofilament heavy subunit (pNF-H) in peripheral blood and CSF as a potential prognostic biomarker in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 84: 467-472.
46. Brettschneider J, Petzold A, Süssmuth SD, Ludolph AC, Tumani H (2006) Axonal damage markers in cerebrospinal fluid are increased in ALS. Neurology 66: 852-856. (Pubitemid 43739759)
47. Ganesalingam J, An J, Bowser R, Andersen PM, Shaw CE (2013) pNfH is a promising biomarker for ALS. Amyotroph Lateral Scler & Frontotemp Degen 14: 146-149.
48. Foerster BR, Dwamena BA, Petrou M, Carlos RC, Callaghan BC, et al. (2012) Diagnostic accuracy using diffusion tensor imaging in the diagnosis of ALS: a meta-analysis. Acad Radiol 19: 1075-1086.